Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network
- PMID: 20216459
- PMCID: PMC2939167
- DOI: 10.1097/HTR.0b013e3181d27fe3
Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network
Abstract
Background: Traumatic brain injury (TBI) involves several aspects of a patient's condition, including physical, mental, emotional, cognitive, social, and functional changes. Therefore, a clinical trial with individuals with TBI should consider outcome measures that reflect their global status.
Methods: We present the work of the National Institute of Child Health and Development-sponsored Traumatic Brain Injury Clinical Trials Network Outcome Measures subcommittee and its choice of outcome measures for a phase III clinical trial of patients with complicated mild to severe TBI.
Results: On the basis of theoretical and practical considerations, the subcommittee recommended the adoption of a core of 9 measures that cover 2 different areas of recovery: functional and cognitive. These measures are the Extended Glasgow Outcome Scale; the Controlled Oral Word Association Test; the Trail Making Test, Parts A and B; the California Verbal Learning Test-II; the Wechsler Adult Intelligence Scale-III Digit Span subtest; the Wechsler Adult Intelligence Scale-III Processing Speed Index; and the Stroop Color-Word Matching Test, Parts 1 and 2.
Conclusions: The statistical methods proposed to analyze these measures using a global test procedure, along with research and methodological and regulatory issues involved with the use of multiple outcomes in a clinical trial, are discussed.
References
-
- Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14(6):602–615. - PubMed
-
- Ragnarsson KT. Traumatic brain injury research since the 1998 NIH Consensus Conference: accomplishments and unmet goals. J Head Trauma Rehabil. 2006;21(5):379–387. - PubMed
-
- Tilley BC, Marler J, Geller NL, et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke. 1996;27(11):2136–2142. - PubMed
-
- Temkin NR, Anderson GD, Winn HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol. 2007;6(1):29–38. - PubMed
Publication types
MeSH terms
Grants and funding
- U01HD042823/HD/NICHD NIH HHS/United States
- U01HD042653/HD/NICHD NIH HHS/United States
- U01 HD042689/HD/NICHD NIH HHS/United States
- U01HD042678/HD/NICHD NIH HHS/United States
- U01 HD042687/HD/NICHD NIH HHS/United States
- U01 HD042823/HD/NICHD NIH HHS/United States
- U01HD042652/HD/NICHD NIH HHS/United States
- U01 HD042653/HD/NICHD NIH HHS/United States
- U01 HD042738/HD/NICHD NIH HHS/United States
- U01HD042689/HD/NICHD NIH HHS/United States
- U01HD042736/HD/NICHD NIH HHS/United States
- U01 HD042736/HD/NICHD NIH HHS/United States
- U01HD042686/HD/NICHD NIH HHS/United States
- U01 HD042652/HD/NICHD NIH HHS/United States
- U01 HD042678/HD/NICHD NIH HHS/United States
- U01 HD042686/HD/NICHD NIH HHS/United States
- U01HD042687/HD/NICHD NIH HHS/United States
- U01HD042738/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical